While I tend to agree with what your saying we need not forget ours is very new & disruptive technology not used in the brain imaging space where the CT scanner is already proven and used globally as standard of care currently. I may be wrong but surely the trials and data evidence would be captured easier/faster for MX1s approvals compared to all the clinical validated data we would need to supply FDA for approvals.
Not saying one device will be better than the other there is most probably room for both but our scanner being very portable user friendly, non-invasive and excellent for post care monitoring will hopefully be the major benefit and selling point to major health companies worldwide and also my hope is a partner the likes of Nvidia getting on board at some stage to also help promote their AI technology which we use......now wouldn't that be great !
Another big tick and on time announcement from EMV.
While I tend to agree with what your saying we need not forget...
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.10 |
Change
-0.050(2.33%) |
Mkt cap ! $179.3M | |||
| Open | High | Low | Value | Volume |
| $2.11 | $2.14 | $2.09 | $165.5K | 78.52K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $2.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.14 | 4981 | 1 |
View Market Depth
| Last trade - 16.10pm 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.11 |
Change
-0.050 ( 1.86 %) |
||||
| Open | High | Low | Volume | ||
| $2.11 | $2.15 | $2.10 | 16089 | ||
| Last updated 15.58pm 29/04/2024 ? | |||||
| EMV (ASX) Chart |